Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
BIOTECHNOLOGY VALUE FUND L P
- As of  06/05/24, 03:02:31 AM:   62 Insider Transactions.

Email this page to a friend.

Buy/Sell* 1 Yr Return** Filed Date Subject Symbol Pct Owned Details
B 2020-11-20 17:23:15.0 Olema Pharmaceuticals n/a 16.6% view
B 2020-11-16 17:29:09.0 CYTOKINETICS INC CYTK 10.4% view
S 2020-11-13 17:27:53.0 FIVE PRIME THERAPEUTICS FPRX 3.3% view
S 2020-11-12 17:13:50.0 INFINITY PHARMACEUTICALS INFI 27.1% view
B 2020-11-12 17:11:34.0 Calliditas Therapeutics AB n/a 14.9% view
B 2020-11-10 16:58:41.0 CytomX Therapeutics CTMX 10.0% view
B 2020-11-09 17:26:18.0 MIRAGEN THERAPEUTICS MGEN 9.99% view
S 2020-11-03 16:39:02.0 BioLineRx Ltd n/a 1.9% view
B 2020-10-20 08:59:04.0 CONTRAFECT Corp CFRX 9.99% view
S 2020-10-13 17:18:05.0 Erytech Pharma S n/a 23.5% view
B 2020-10-09 17:20:16.0 XOMA Corp XOMA 38.0% view
B 2020-10-08 17:26:00.0 FIVE PRIME THERAPEUTICS FPRX 22.8% view
B 2020-10-05 17:26:18.0 Novus Therapeutics NVUS 15.6% view
B 2020-09-23 17:28:53.0 XOMA Corp XOMA 38.0% view
B 2020-08-25 17:27:50.0 Kymera Therapeutics n/a 5.9% view
B 2020-08-25 12:32:36.0 Principia Biopharma Inc PRNB 15.7% view
B 2020-08-19 13:49:28.0 Principia Biopharma Inc PRNB 15.7% view
B 2020-07-20 16:35:01.0 Therapeutics Acquisition Corp n/a 5.9% view
B 2020-07-20 16:22:30.0 Unum Therapeutics Inc UMRX 9.99% view
S 2020-06-29 18:25:58.0 Celldex Therapeutics CLDX 7.2% view
B 2020-06-25 17:13:05.0 IDEAYA Biosciences IDYA 11.0% view
B 2020-06-22 17:17:24.0 CURIS INC CRIS 7.2% view
B 2020-06-08 10:27:37.0 Merus N MRUS 17.2% view
S 2020-06-01 17:37:41.0 BioLineRx Ltd n/a 11.8% view
S 2020-05-29 17:06:27.0 Calithera Biosciences CALA 10.1% view
B 2020-05-22 17:22:01.0 XOMA Corp XOMA 36.6% view
B 2020-04-01 16:53:13.0 XOMA Corp XOMA 36.4% view
B 2020-03-16 17:23:54.0 Kura Oncology CTMX 7.0% view
B 2020-03-04 17:29:19.0 CTI BIOPHARMA CORP PIRS 10.7% view
B 2020-02-18 16:35:20.0 Corvus Pharmaceuticals SPRO 9.99% view
S 2020-02-14 17:00:52.0 GENOCEA BIOSCIENCES GNCA 6.5% view
S 2020-02-14 16:03:25.0 BioLineRx Ltd n/a 17.5% view
B 2020-02-14 15:29:42.0 Principia Biopharma Inc PRNB 5.2% view
S 2020-02-14 15:25:39.0 Molecular Templates MTEM 8.2% view
S 2020-02-14 15:21:44.0 Galmed Pharmaceuticals Ltd n/a 8.7% view
B 2020-02-14 15:17:34.0 Verastem VSTM 8.5% view
B 2020-02-14 15:13:48.0 GLYCOMIMETICS INC GLYC 17.0% view
B 2020-02-14 15:09:41.0 ChemoCentryx n/a 16.8% view
S 2020-02-14 15:05:45.0 SpringWorks Therapeutics MRUS 11.0% view
B 2020-02-14 15:00:03.0 Arcus Biosciences RCUS 7.8% view
S 2020-02-14 14:56:12.0 Brickell Biotech VICL 8.3% view
S 2020-02-14 14:52:09.0 Corvus Pharmaceuticals CDTX 9.99% view
B 2020-02-14 14:48:56.0 ALPINE IMMUNE SCIENCES CALA 15.1% view
S 2020-02-14 14:44:05.0 Mersana Therapeutics MRSN 7.4% view
B 2020-02-14 14:39:58.0 Replimune Group REPL 6.5% view
B 2020-02-14 14:37:20.0 MEI Pharma MEIP 6.4% view
B 2020-02-14 14:33:43.0 Ovid Therapeutics Inc OVID 9.99% view
B 2020-02-13 17:30:14.0 CTI BIOPHARMA CORP CTIC 19.99% view
B 2020-02-03 21:31:21.0 INFINITY PHARMACEUTICALS INFI 30.6% view
B 2020-01-06 22:00:00.0 FIVE PRIME THERAPEUTICS FPRX 21.4% view
S 2019-12-20 19:24:08.0 Merus N n/a 11.6% view
B 2019-11-08 17:17:03.0 Principia Biopharma Inc PRNB 5.0% view
B 2019-10-09 17:30:31.0 FIVE PRIME THERAPEUTICS FPRX 11.3% view
B 2019-09-23 17:12:49.0 AC Immune SA n/a 16.7% view
B 2019-09-09 16:44:45.0 GLYCOMIMETICS INC GLYC 10.3% view
S 2019-08-07 16:56:55.0 CONCERT PHARMACEUTICALS CNCE 5.9% view
B 2019-06-27 18:06:19.0 Calithera Biosciences CALA 13.1% view
B 2019-06-07 16:20:29.0 IDEAYA Biosciences VSTM 7.5% view
S 2019-05-10 16:24:53.0 Novus Therapeutics OMED 0.0% view
B 2019-04-23 09:27:25.0 VICAL INC VICL 9.99% view
B 2019-04-02 14:50:20.0 Replimune Group REPL 5.1% view
S 2019-03-21 17:10:23.0 OncoMed Pharmaceuticals Inc OMED 10.4% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.
** Since most institutions are long investors, only returns for long transactions are shown here.